About

Hailin Wang is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques in gynecologic oncology and hepatobiliary surgery. Wang’s major contributions center on evaluating the safety, efficacy, and comparative outcomes of robot-assisted surgery versus conventional laparoscopy. In a landmark 2020 multicenter retrospective study (40 citations), Wang demonstrated that robot-assisted radical hysterectomy offers comparable oncologic outcomes to abdominal radical hysterectomy for cervical cancer, challenging traditional surgical paradigms. Further work, including a 2019 study on intra- and postoperative outcomes (6 citations) and a meta-analysis on robotic hepatectomy (2025, 4 citations), systematically quantifies the benefits of robotic platforms—such as reduced blood loss and shorter hospital stays—while highlighting areas for caution. Wang’s research has directly informed clinical decision-making in China and globally, providing critical evidence for the adoption of robotic surgery in complex oncologic cases. By rigorously comparing robotic, laparoscopic, and open approaches, Wang has helped define best practices for treating cervical cancer and liver tumors, making a lasting impact on surgical oncology and patient recovery.

Research Focus

Key Achievements

4
H-Index
4
Papers
55
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Comparison between robot-assisted radical hysterectomy and abdominal radical hysterectomy for cervical cancer: A multicentre retrospective study
40 citations · 2020
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: Medical Center Hospital, Gansu Provincial Hospital, Gansu University of Traditional Chinese Medicine, Yulin University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago